Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 1,184,000 | 697,492 |
| Accounts receivable | -60,000 | -322,193 |
| Accounts payable and accrued liabilities | -695,000 | 210,324 |
| Other Working Capital | -866,000 | 503,741 |
| Other Operating Activity | 5,413,000 | 4,277,972 |
| Operating Cash Flow | $4,976,000 | $5,367,336 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -448,000 | -312,565 |
| Net Acquisitions | -2,621,000 | -170,000 |
| Purchase Of Investment | -93,000 | -4,213 |
| Sale Of Investment | 1,000 | 6 |
| Other Investing Activity | -1,870,000 | 417 |
| Investing Cash Flow | $-5,031,000 | $-486,355 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | N/A | -34,766 |
| Other Financing Activity | 65,000 | -4,846,385 |
| Financing Cash Flow | $65,000 | $-4,881,151 |
| Beginning Cash Position | 0 | 207 |
| End Cash Position | 10,000 | 37 |
| Net Cash Flow | $10,000 | $-170 |
| Free Cash Flow | ||
| Operating Cash Flow | 4,976,000 | 5,367,336 |
| Capital Expenditure | -448,000 | -312,565 |
| Free Cash Flow | 4,528,000 | 5,054,771 |